Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma

American Journal of Surgical Pathology

Volumn 31, Issue 8, 2007, Pages 1168-1174

  Malpica, Anais ^a   Deavers, Michael T ^a   Tornos, Carmen ^b,g   Kurman, Robert J ^c   Soslow, Robert ^b   Seidman, Jeffrey D ^d   Munsell, Mark F ^a   Gaertner, Erich ^e   Frishberg, David ^f   Silva, Elvio G ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

^e Sarasota Pathology   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

^g STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cancer; Grading; High grade serous carcinoma; Low grade serous carcinoma; Ovary; Pathology; Serous carcinoma; Tumor

Indexed keywords

ARTICLE; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; OVARY CARCINOMA; PATHOLOGIST; STANDARDIZATION; STATISTICAL ANALYSIS;

CELL NUCLEUS; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; OBSERVER VARIATION; OVARIAN NEOPLASMS; PROGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 34547627444     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31803199b0     Document Type: Article

References (23)

1. Anttila MA, Ji H, Juhola MT, et al. The prognostic significance of p53 expression quantitated by computerized image analysis in epithelial ovarian cancer. Int J Gynecol Pathol. 1999;18:42-51.
2. Bertelsen K, Holund B, Andersen E. Reproducibility and prognostic value of histologic type and grade in early epithelial ovarian cancer. Int J Gynecol Cancer. 1993;3:72-79.
3. Brugghe J, Baak JPA, Wiltshaw E, et al. Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment. Gynecol Oncol. 1998;68:47-53.
4. Carey MS, Dembo AJ, Simm JE, et al. Testing the validity of a prognostic classification in patients with surgically optimal ovarian carcinoma: a 15-year review. Int J Gynecol Cancer. 1993;3:24-35.
5. Clement PB, Young RH. Surface epithelial-stromal tumors: general features, serous tumors, and mucinous tumors. In: Clement PB, Young RH, eds. Atlas of Gynecologic Surgical Pathology. Philadelphia, PA: WB Saunders; 2000:289-301.
6. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37-46.
7. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York: John Wiley & Sons; 1981.
8. Gadducci A, Sartori E, Maggino T, et al. Can we predict a high-risk group in stage I epithelial ovarian cancer? Int J Gynecol Cancer. 1993;3:226-230.
9. International Federation of Gynecology and Obstetrics (FIGO). Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scand. 1971;50:1-7.
10. Lee KR, Tavassoli FA, Prat J, et al. Surface epithelial-stromal tumors: serous tumors. In: Scully RE ed., in collaboration with Sobin LH and pathologists from 5 countries. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Breast and Female Genital Organs. Lyon: IARC Press; 2003:117-161.
11. Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinomas using a two-tier system. Mod Pathol. 2002;849:202A.
12. Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 2004;28:496-504.
13. Mayr D, Diebold J. Grading of ovarian carcinomas. Int J Gynecol Pathol. 2002;19:348-353.
14. McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psycometrika. 1947;12:153-157.
15. Russell P, Farnsworth A. Serous tumors. In: Russell P, Farnsworth A, eds. Surgical Pathology of the Ovaries. 2nd ed. Dinburg, UK: Churchill Livingstone; 1997:239-271.
16. Russell P, Robboy SJ, Anderson MC. Epithelial/stromal tumors: serous tumors. In: Robboy SJ, Anderson MC, eds. Pathology of the Female Reproductive Tract. London: Churchill Livingstone; 2002:539-605.
17. Scully RE, Young RH, Clement PB. Surface epithelial-stromal tumors: serous tumors. In: Scully RE, Young RH, Clement PB, eds. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube and Broad Ligament: Atlas of Tumor Pathology, 3rd series, fascicle 23. Washington, DC: Armed Forces Institute of Pathology; 1998:51-79.
18. Seidman JD, Russell P, Kurman R. Surface epithelial tumors of the ovary. In: Kurman RJ, ed. Blaunstein's Pathology of the Female Genital Tract. 5th ed. New York: Springer-Verlag; 2001: 791-904.
19. Shimizu Y, Kamoi S, Amada S, et al. Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features - problems involved in the architectural grading system. Gynecol Oncol. 1998;70:2-12.
20. Shimizu Y, Kamoi S, Amada S, et al. Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up. Cancer. 1998;82:893-901.
21. Silverberg SG. Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol. 2000;19:135-141.
22. Singer G, Stöhr R, Cope L, et al. Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis. A mutational analysis with immunohistochemical correlation. Am J Surg Pathol. 2005;29:218-224.
23. Vacher-Lavenu MC, Le Tournear A, Duvillard P, et al. Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovary study group. Bull Cancer. 1993;80:135-141.